Hybrid AI Stethoscopes

Eko Health Combines Traditional and Digital Listening

Eko Health is introducing hybrid AI stethoscopes with its CORE 300, a medical device that combines conventional listening with digital sound enhancement. Clinicians can switch between both methods by rotating the chestpiece, maintaining familiar examination techniques while gaining access to AI-assisted heart murmur detection through connected software.

The FDA-cleared device offers up to 35 times sound amplification, noise cancellation, and a built-in heart rate display. Healthcare professionals can also record and review heart and lung sounds through the Eko app. Designed for pediatric and adult patients, the stethoscope supports clearer examinations in busy clinical environments.

For Eko Health, the launch creates opportunities to expand digital diagnostic tools among healthcare professionals. Its pricing alongside premium traditional stethoscopes and planned international rollout could encourage wider adoption of AI-supported examinations, particularly in healthcare settings with limited access to specialists.

Image Credit: Eko Health

Hybrid Diagnostic Devices
Medical tools that preserve familiar clinical workflows while embedding digital intelligence create openings for faster adoption of AI-enabled care.
AI-assisted Auscultation
Connected sound analysis in routine examinations expands access to specialist-grade insights for heart and lung screening.
Clinical Noise Reduction
Enhanced amplification and cancellation technologies improve diagnostic confidence in busy healthcare environments where acoustic clarity is often limited.

Industries Being Reshaped

Medical Devices
Hybrid hardware that blends analog usability with software-driven diagnostics reshapes premium equipment categories for clinicians.
Digital Health
App-connected examination tools generate new data streams that support longitudinal monitoring, remote review, and AI-assisted decision-making.
Primary Care
Point-of-care diagnostic augmentation strengthens frontline screening capabilities in clinics with limited specialist availability.
SCORE
9.2 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America, Europe
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 100%
Activity 75%
Freshness 100%